Pipeline Vantage Embolization Device with Shield Technology
FDA premarket approval P100018/S042 · decided 2023-10-25
Approval details
- PMA number
- P100018
- Supplement
- S042
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Pipeline Vantage Embolization Device with Shield Technology
- Generic name
- Intracranial aneurysm flow diverter
- Applicant
- Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
- Date received
- 2023-09-28
- Decision date
- 2023-10-25
- Days to decision
- 27 days
- Decision code
- OK30
- Product code
- OUT
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Irvine, CA
- Statement
- approval for manufacturing facility location change and a new degreasing solvent for the solder preform ring component of the Pipeline Vantage Embolization Device with Shield Technology
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.